Sygnature Discovery

Sygnature Discovery is a prominent integrated drug discovery contract research organisation with facilities in the UK and Canada, specialising in the development of therapeutic compounds across various medical fields including oncology, neuroscience, and immunology. With a robust team of over 1,000 professionals, including 900 scientists, they focus on advancing drug candidates from target validation to clinical candidate stages.

The organisation offers a comprehensive suite of services that encompass bioscience, chemistry, and computer-aided drug design, ensuring efficient progression through the drug development pipeline. Established in 2011, Sygnature Discovery has established a proven track record with the successful delivery of numerous novel preclinical and clinical compounds.

Generated from the website